Performance of a 27 kDa Fasciola hepatica Antigen in the Diagnosis of Human Fascioliasis

Reza Shafiei; Bahador Sarkari; Seyed Mahmoud Sadjjadi

doi:10.4103/0974-2727.154781

Journal of Laboratory Physicians, Inhaltsverzeichnis

CC BY-NC-ND 4.0 · J Lab Physicians 2015; 7(01): 017-020
DOI: 10.4103/0974-2727.154781

Original Article

Performance of a 27 kDa Fasciola hepatica Antigen in the Diagnosis of Human Fascioliasis

Reza Shafiei

Department of Parasitology and Mycology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran

,

Bahador Sarkari

Basic Sciences in Infectious Diseases Research Center, Shiraz University of Medical Sciences, Shiraz, Iran

,

Seyed Mahmoud Sadjjadi

Department of Parasitology and Mycology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran

› Institutsangaben

Abstract

als PDF herunterladen

ABSTRACT

Background: Serological diagnosis, based on antigenic fractions of the parasite can be used for the early diagnosis of human fascioliasis. The current study aimed to evaluate the efficacy of a 27 kDa immunodominant antigen of Fasciola hepatica adult worms, in an indirect enzyme-linked immunosorbent assay (ELISA) system for serological diagnosis of human fascioliasis.

Materials and Methods: The immunodiagnosis of human fascioliasis, using a 27 kDa immunodominant antigen, purified from F. hepatica somatic antigens (SAs), was evaluated by Western blotting and ELISA with sera samples of human fascioliasis patients, healthy controls and patients with other parasitic infections.

Results: Using western blotting, from 12 sera of fascioliasis patients, 11 sera (91.6%) detected the 27 kDa subunit. None of 30 samples from healthy controls or 32 sera from nonfascioliasis patients reacted with the 27 kDa antigen. Accordingly, sensitivity and specificity of the system was found to be 91.6% and 100%, respectively. The 27 kDa antigen was purified from the SAs and was used in an indirect ELISA system. Of 15 sera of fascioliasis patients, all (100%) were found to be positive by ELISA whereas only 4 cases (6.25%) of nonfascioliasis patients or healthy controls were false-positive by this system. Accordingly, the sensitivity and specificity of the test were 100% and 93.6%, respectively.

Conclusion: Findings of this study demonstrated that both Western blotting and the indirect ELISA, based on the 27 kDa subunit of F. hepatica SA, are reliable methods for serodiagnosis of human fascioliasis.

Key words

Enzyme-linked immunosorbent assay - fascioliasis - immunodiagnosis

PDF (703 kb)

Referenzen

REFERENCES
1 Mas-Coma S, Valero MA, Bargues MD. Chapter 2. Fasciola, lymnaeids and human fascioliasis, with a global overview on disease transmission, epidemiology, evolutionary genetics, molecular epidemiology and control. Adv Parasitol 2009;69:41-146.
2 Kabaalioglu A, Cubuk M, Senol U, Cevikol C, Karaali K, Apaydin A, et al. Fascioliasis: US, CT, and MRI findings with new observations. Abdom Imaging 2000;25:400-4.
3 Hillyer GV. Immunodiagnosis of human and animal fascioliasis. In: Dalton JP, editor. Fasciolosis. Oxon, Wallingford, London, UK: CABI Publishing; 1998. p. 435-48.
4 O′Neill SM, Parkinson M, Strauss W, Angles R, Dalton JP. Immunodiagnosis of Fasciola hepatica infection (fascioliasis) in a human population in the Bolivian Altiplano using purified cathepsin L cysteine proteinase. Am J Trop Med Hyg 1998;58:417-23.
5 Espinoza JR, Maco V, Marcos L, Saez S, Neyra V, Terashima A, et al. Evaluation of Fas2-ELISA for the serological detection of Fasciola hepatica infection in humans. Am J Trop Med Hyg 2007;76:977-82.
6 O′Neill SM, Parkinson M, Dowd AJ, Strauss W, Angles R, Dalton JP. Short report: Immunodiagnosis of human fascioliasis using recombinant Fasciola hepatica cathepsin L1 cysteine proteinase. Am J Trop Med Hyg 1999;60:749-51.
7 Rokni MB, Massoud J, Hanilo A. Comparison of adult somatic and cysteine proteinase antigens of Fasciola gigantica in enzyme linked immunosorbent assay for serodiagnosis of human fasciolosis. Acta Trop 2003;88:69-75.
8 Rokni MB, Massoud J, O′Neill SM, Parkinson M, Dalton JP. Diagnosis of human fasciolosis in the Gilan province of Northern Iran: Application of cathepsin L-ELISA. Diagn Microbiol Infect Dis 2002;44:175-9.
9 Rahimi MT, Ashrafi K, Koosha S, Abdi J, Rokni MB. Evaluation of fast-ELISA versus standard-ELISA to diagnose human fasciolosis. Arch Iran Med 2011;14:18-21.
10 Shafiei R, Sarkari B, Moshfe A. A consistent PCR-RFLP assay based on ITS-2 ribosomal DNA for differentiation of Fasciola species. Iran J Basic Med Sci 2013;16:1266-9.
11 Sarkari B, Sadjjadi SM, Abidi H, Izadpanah A, Kazemian S, Rafati A. Application of western blotting using native antigen B for serodiagnosis of human cystic echinococcosis. Iran J Parasitol 2007;2:7-12.
12 Tech Tip N.51, T.S. Available from: http://www.thermo.com/pierce. [Last accessed on 2011 Sep 10].
13 Sarkari B, Ghobakhloo N, Moshfea A, Eilami O. Seroprevalence of human fasciolosis in a new-emerging focus of fasciolosis in Yasuj district, southwest of Iran. Iran J Parasitol 2012;7:15-20.
14 Intapan PM, Maleewong W, Nateeworanart S, Wongkham C, Pipitgool V, Sukolapong V, et al. Immunodiagnosis of human fascioliasis using an antigen of Fasciola gigantica adult worm with the molecular mass of 27 kDa by a dot-ELISA. Southeast Asian J Trop Med Public Health 2003;34:713-7.
15 Cordova M, Herrera P, Nopo L, Bellatin J, Naquira C, Guerra H, et al. Fasciola hepatica cysteine proteinases: Immunodominant antigens in human fascioliasis. Am J Trop Med Hyg 1997;57:660-6.
16 Kim K, Yang HJ, Chung YB. Usefulness of 8 kDa protein of Fasciola hepatica in diagnosis of fascioliasis. Korean J Parasitol 2003;41:121-3.
17 Figueroa-Santiago O, Delgado B, Espino AM. Fasciola hepatica saposin-like protein-2-based ELISA for the serodiagnosis of chronic human fascioliasis. Diagn Microbiol Infect Dis 2011;70:355-61.
18 Demerdash ZA, Diab TM, Aly IR, Mohamed SH, Mahmoud FS, Zoheiry MK, et al. Diagnostic efficacy of monoclonal antibody based sandwich enzyme linked immunosorbent assay (ELISA) for detection of Fasciola gigantica excretory/secretory antigens in both serum and stool. Parasit Vectors 2011;4:176.
19 Dalimi A, Hadighi R, Madani R. Partially purified fraction (PPF) antigen from adult Fasciola gigantica for the serodiagnosis of human fascioliasis using Dot-ELISA technique. Ann Saudi Med 2004;24:18-20.
20 Yamasaki H, Aoki T, Oya H. A cysteine proteinase from the liver fluke Fasciola spp.: Purification, characterization, localization and application to immunodiagnosis. Jpn J Parasitol 1989;38:374-84.
21 Shaker ZA, Demerdash ZA, Mansour WA, Hassanein HI, el Baz HG, el Gindy HI. Evaluation of specific Fasciola antigen in the immunodiagnosis of human fascioliasis in Egypt. J Egypt Soc Parasitol 1994;24:463-70.
22 Maleewong W, Intapan PM, Tomanakarn K, Wongkham C. Antigenic components of somatic extract from adult Fasciola gigantica recognized by infected human sera. Asian Pac J Allergy Immunol 1997;15:213-8.